Literature DB >> 32437303

Treatment of Obesity in Mitigating Metabolic Risk.

Sean P Heffron1,2, Johnathon S Parham2, Jay Pendse3,4, José O Alemán3.   

Abstract

Through diverse mechanisms, obesity contributes to worsened cardiometabolic health and increases rates of cardiovascular events. Effective treatment of obesity is necessary to reduce the associated burdens of diabetes mellitus, cardiovascular disease, and death. Despite increasing cardiovascular outcome data on obesity interventions, only a small fraction of the population with obesity are optimally treated. This is a primary impetus for this article in which we describe the typical weight loss, as well as the associated impact on both traditional and novel cardiovascular disease risk factors, provided by the 4 primary modalities for obtaining weight loss in obesity-dietary modification, increasing physical activity, pharmacotherapy, and surgery. We also attempt to highlight instances where changes in metabolic risk are relatively specific to particular interventions and appear at least somewhat independent of weight loss. Finally, we suggest important areas for further research to reduce and prevent adverse cardiovascular consequences due to obesity.

Entities:  

Keywords:  cardiovascular disease; exercise; obesity; risk factor; weight loss

Mesh:

Substances:

Year:  2020        PMID: 32437303      PMCID: PMC7343291          DOI: 10.1161/CIRCRESAHA.119.315897

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  238 in total

1.  Aerobic exercise, lipids and lipoproteins in overweight and obese adults: a meta-analysis of randomized controlled trials.

Authors:  G A Kelley; K S Kelley; Z Vu Tran
Journal:  Int J Obes (Lond)       Date:  2005-08       Impact factor: 5.095

2.  Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Frank L Greenway; Ken Fujioka; Raymond A Plodkowski; Sunder Mudaliar; Maria Guttadauria; Janelle Erickson; Dennis D Kim; Eduardo Dunayevich
Journal:  Lancet       Date:  2010-07-29       Impact factor: 79.321

3.  Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls.

Authors:  George P Nassis; Katerina Papantakou; Katerina Skenderi; Maria Triandafillopoulou; Stavros A Kavouras; Mary Yannakoulia; George P Chrousos; Labros S Sidossis
Journal:  Metabolism       Date:  2005-11       Impact factor: 8.694

4.  Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis.

Authors:  Matthew Martin; Alec Beekley; Randy Kjorstad; James Sebesta
Journal:  Surg Obes Relat Dis       Date:  2009-07-17       Impact factor: 4.734

5.  Comparison of Diet versus Exercise on Metabolic Function and Gut Microbiota in Obese Rats.

Authors:  Rebecca J Welly; Tzu-Wen Liu; Terese M Zidon; Joe L Rowles; Young-Min Park; T Nicholas Smith; Kelly S Swanson; Jaume Padilla; Victoria J Vieira-Potter
Journal:  Med Sci Sports Exerc       Date:  2016-09       Impact factor: 5.411

6.  Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.

Authors:  Lars Sjöström; Markku Peltonen; Peter Jacobson; Sofie Ahlin; Johanna Andersson-Assarsson; Åsa Anveden; Claude Bouchard; Björn Carlsson; Kristjan Karason; Hans Lönroth; Ingmar Näslund; Elisabeth Sjöström; Magdalena Taube; Hans Wedel; Per-Arne Svensson; Kajsa Sjöholm; Lena M S Carlsson
Journal:  JAMA       Date:  2014-06-11       Impact factor: 56.272

Review 7.  Intestinal and Gastric Origins for Diabetes Resolution After Bariatric Surgery.

Authors:  Caroline A Andrew; Devika Umashanker; Louis J Aronne; Alpana P Shukla
Journal:  Curr Obes Rep       Date:  2018-06

8.  Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption.

Authors:  Antje Damms-Machado; Suparna Mitra; Asja E Schollenberger; Klaus Michael Kramer; Tobias Meile; Alfred Königsrainer; Daniel H Huson; Stephan C Bischoff
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

9.  Do Changes in Innate Immunity Underlie the Cardiovascular Benefits of Exercise?

Authors:  Phillip Chuong; Marcin Wysoczynski; Jason Hellmann
Journal:  Front Cardiovasc Med       Date:  2019-05-29

Review 10.  Pathways and mechanisms linking dietary components to cardiometabolic disease: thinking beyond calories.

Authors:  K L Stanhope; M I Goran; A Bosy-Westphal; J C King; L A Schmidt; J-M Schwarz; E Stice; A C Sylvetsky; P J Turnbaugh; G A Bray; C D Gardner; P J Havel; V Malik; A E Mason; E Ravussin; M Rosenbaum; J A Welsh; C Allister-Price; D M Sigala; M R C Greenwood; A Astrup; R M Krauss
Journal:  Obes Rev       Date:  2018-05-14       Impact factor: 9.213

View more
  11 in total

1.  The effect of individualized exercise prescriptions combined with dietary management on blood glucose in the second-and-third trimester of gestational diabetes mellitus.

Authors:  Ying Zhang; Yingying Han; Qiuhong Dong
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Introduction to the Obesity, Metabolic Syndrome, and CVD Compendium.

Authors:  Kathryn J Moore; Ravi Shah
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

3.  The effectiveness of diet intervention in improving the metabolism of overweight and obese women: a systematic review and meta-analysis.

Authors:  Mengkun Chen; Qiuli Chen; Wenjun Liu; Hui Tong; Yuedan Wu
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

4.  Hydrogen Sulfide Attenuates High-Fat Diet-Induced Obesity: Involvement of mTOR/IKK/NF-κB Signaling Pathway.

Authors:  Maofang Zhao; Yuan Cheng; Xiaoxuan Wang; Xiaoying Cui; Xiaojing Cheng; Qian Fu; Yilin Song; Peiquan Yu; Yi Liu; Yinghua Yu
Journal:  Mol Neurobiol       Date:  2022-09-02       Impact factor: 5.682

Review 5.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Authors:  Tiffany M Powell-Wiley; Paul Poirier; Lora E Burke; Jean-Pierre Després; Penny Gordon-Larsen; Carl J Lavie; Scott A Lear; Chiadi E Ndumele; Ian J Neeland; Prashanthan Sanders; Marie-Pierre St-Onge
Journal:  Circulation       Date:  2021-04-22       Impact factor: 29.690

Review 6.  Obesity, kidney dysfunction, and inflammation: interactions in hypertension.

Authors:  John E Hall; Alan J Mouton; Alexandre A da Silva; Ana C M Omoto; Zhen Wang; Xuan Li; Jussara M do Carmo
Journal:  Cardiovasc Res       Date:  2021-07-07       Impact factor: 10.787

7.  Genotype and Successive Harvests Interaction Affects Phenolic Acids and Aroma Profile of Genovese Basil for Pesto Sauce Production.

Authors:  Michele Ciriello; Luigi Formisano; Christophe El-Nakhel; Marios C Kyriacou; Georgios A Soteriou; Fabiana Pizzolongo; Raffaele Romano; Stefania De Pascale; Youssef Rouphael
Journal:  Foods       Date:  2021-01-30

Review 8.  Advances in Phenotyping Obesity and in Its Dietary and Pharmacological Treatment: A Narrative Review.

Authors:  Roberta Pujia; Maria Grazia Tarsitano; Franco Arturi; Antonino De Lorenzo; Andrea Lenzi; Arturo Pujia; Tiziana Montalcini
Journal:  Front Nutr       Date:  2022-02-15

Review 9.  Ten things to know about ten cardiovascular disease risk factors.

Authors:  Harold E Bays; Pam R Taub; Elizabeth Epstein; Erin D Michos; Richard A Ferraro; Alison L Bailey; Heval M Kelli; Keith C Ferdinand; Melvin R Echols; Howard Weintraub; John Bostrom; Heather M Johnson; Kara K Hoppe; Michael D Shapiro; Charles A German; Salim S Virani; Aliza Hussain; Christie M Ballantyne; Ali M Agha; Peter P Toth
Journal:  Am J Prev Cardiol       Date:  2021-01-23

10.  High plasma renin activity associates with obesity-related diabetes and arterial hypertension, and predicts persistent hypertension after bariatric surgery.

Authors:  Lucia La Sala; Elena Tagliabue; Elaine Vieira; Antonio E Pontiroli; Franco Folli
Journal:  Cardiovasc Diabetol       Date:  2021-06-09       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.